MedPath

Adaptation to Ozone in Individuals With Asthma/Exercise-induced Bronchoconstriction

Not Applicable
Conditions
Asthma, Exercise-Induced
Asthma
Exercise Induced Asthma
Exercise Induced Bronchospasm
Interventions
Behavioral: Exercise
Other: Filtere Air
Other: Ozone
Registration Number
NCT05105529
Lead Sponsor
University of British Columbia
Brief Summary

Researchers found that impairments in the cardiopulmonary system caused by acute exposure to ozone were outweighed by repeated exposures to ozone. The goal of this study is to confirm there will be an adaptation similar to what was previously proved but in individuals with asthma and exercise-induced bronchoconstriction (EIB). The purpose is to examine adaptive responses in a randomized cross-over trial in which physically active individuals will perform submaximal exercise on five days in ozone and filtered air exposures separated by a washout period.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Recreationally active individuals
  • Diagnosed asthma and/or mild exercise-induced bronchoconstriction: defined by an FEV1 fall equal to or greater than 10% but lower than 25% in the eucapnic hyperventilatory test.
  • Able to securely perform a maximal exercise test (responded 'no' to all questions on the PAR-Q+ questionnaire)
  • Able to communicate in English
Exclusion Criteria
  • Diagnosed with any cardiorespiratory or vascular diseases
  • Pregnant or potentially pregnant
  • Non-smoking
  • Lower limb musculoskeletal injury or lower limb limitation to cycle on a bicycle ergometer
  • Recent respiratory symptoms or upper tract infection within 4 weeks
  • On vitamin (e.g., C or E) supplementation

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Filtered AirFiltere AirParticipants of the sham group will also perform sub-maximal exercise (60% of VO2max for 30 minutes) on a cycle ergometer similar to intervention. However, only in this group, the ozone generator will not be activated so that just filtered air will be delivered to the participant while performing each exercise session.
Ozone (O3) groupExerciseParticipants of the experimental group will perform sub-maximal exercise (60% of VO2max for 30 minutes) on a cycle ergometer while inhaling 170ppb ozone delivered continuously during each exercise session.
Ozone (O3) groupOzoneParticipants of the experimental group will perform sub-maximal exercise (60% of VO2max for 30 minutes) on a cycle ergometer while inhaling 170ppb ozone delivered continuously during each exercise session.
Filtered AirExerciseParticipants of the sham group will also perform sub-maximal exercise (60% of VO2max for 30 minutes) on a cycle ergometer similar to intervention. However, only in this group, the ozone generator will not be activated so that just filtered air will be delivered to the participant while performing each exercise session.
Primary Outcome Measures
NameTimeMethod
Change in FEV1 from baseline to 10 minutes after exerciseMeasured at baseline and 10 minutes after each exercise bout

Measurement of pulmonary function: forced exhaled volume in the first second (FEV1) in liters

Change in FEF25-75 from baseline to 10 minutes after exerciseMeasured at baseline and 10 minutes after each exercise bout

Measurement of pulmonary function: forced expiratory flow at 25-75% of pulmonary volume in liters per second (L/s)

Change in FVC from baseline to 10 minutes after exerciseMeasured at baseline and 10 minutes after each exercise bout

Measurement of pulmonary function: forced vital capacity (FVC) in liters

Secondary Outcome Measures
NameTimeMethod
Change in Pulse Wave Velocity (PWV) from baseline to 20 minutes after exerciseMeasured at baseline and 20 minutes after each exercise bout

Velocity (in meters per second) at which the blood pressure pulse propagates through set points in the circulatory system

Change in Fraction of exhaled nitric oxide (FeNO) from baseline to 5 minutes after exerciseMeasured at baseline and 5 minutes after each exercise bout

Non-invasive airway inflammation biomarker (in part per billion, ppb)

Trial Locations

Locations (2)

Environmental Physiology Laboratory

🇨🇦

Vancouver, British Columbia, Canada

University of British Columbia

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath